Effect of extending the platelet storage time on platelet utilization: Predictions from a mathematical model of prophylactic platelet support

Transfusion Medicine

Volumn 17, Issue 2, 2007, Pages 119-127

  Pereira, A ^a   Sanz, C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Blood banking; Mathematical model; Platelet transfusion

Indexed keywords

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; KINETICS; MATHEMATICAL MODEL; PROPHYLAXIS; SHELF LIFE; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION;

BLOOD BANKS; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SURVIVAL; FORECASTING; HUMANS; KINETICS; MODELS, THEORETICAL; PLATELET TRANSFUSION; TIME FACTORS;

EID: 34147108804     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2006.00714.x     Document Type: Article

References (24)

1. AuBuchon, J.P., Cooper, L.K., Leach, M.F., Zuaro, D.E. & Schwartzman, J.D. (2002) Experience with universal bacterial culturing to detect contamination of apheresis platelet units in a hospital transfusion service. Transfusion, 42, 855-861.
2. AuBuchon, J.P., Taylor, H., Holme, S. & Nelson, E. (2005) In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers. Transfusion, 45, 1356-1361.
3. Benjamin, R.J. & Mintz, P.D. (2005) Bacterial detection and extended platelet storage - the next step forward. Transfusion, 45, 1832-1835.
4. Cardigan, R. & Williamson, L.M. (2003) The quality of platelets stored for 7 days. Transfusion Medicine, 13, 173-187.
5. De Wildt-Eggen, J., Nauta, S., Schrijver, J.G., van Marwijk-Kooy, M., Bins, M. & van Prooijen, H.C. (2000) Reactions and platelet increments after transfusion of platelet concentrates in plasma or in additive solution: a prospective randomized study. Transfusion, 40, 398-403.
6. Dijkstra-Tiekstra, M.J., Pietersz, R.N.I., Hendriks, E.C.M., Reesink, H.E. & Huijgens, P.C. (2004) In vivo PLT increments after transfusion of WBC-reduced PLT concentrates stored for up to 7 days. Transfusion, 44, 330-336.
7. Dumont, L.J., AuBuchon, J.P., Whitley, P., Herschel, L.H., Johnson, A., McNeil, D., Sawyer, S. & Roger, J.C. (2002) Seven-day storage of single-donor platelets - recovery and survival in an autologous transfusion study. Transfusion, 42, 847-854.
8. FDA. Reduction of the maximum platelet storage period to 5 days. June 1986 (www.fda.gov/cber/bldmem/060286.pdf - accessed on 26 April 2006)
9. Heddle, N.M., Cook, R.J., Sigouin, C., Slichter, S.J., Murphy, M., Rebulla, P. & the BEST Collaborative. (2006) A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion, 46, 903-911.
10. Hersh, J.K., Hom, E.G. & Brecher, M.E. (1998) Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient. Transfusion, 38, 637-644.
11. Högman, C.F., Eriksson, L., Wallvik, J. & Payrat, J.M. (1997) Clinical and laboratory experience with erythrocyte and platelet preparations from 0.5CPD Erythro-Sol Opti System. Vox Sanguinis, 73, 212-219.
12. Janetzko, K., Cazenave, J.P., Klüter, H. et al. (2005) Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion, 45, 1443-1452.
13. Janssen, M.P., van der Poel, C.L., Buskens, E., Bonneux, L., Bonsel, G.J. & van Hout, B.A. (2006) Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands. Transfusion, 46, 956-965.
14. Klumpp, T.R., Herman, J.H., Gaughan, J.P. et al. (1999) Clinical consequences of alterations in platelet transfusion dose - a prospective, randomized, double-blind trial. Transfusion, 39, 674-681.
15. McCullough, J., Vesole, D.H., Benjamin, R.J. et al. (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood, 104, 1534-1541.
16. Moeremans, K., Warie, H. & Annemans, L. (2006) Assessment of the economic value of the intercept blood system in Belgium. Transfusion Medicine, 16, 17-30.
17. Murphy, S., Snyder, E., Cable, R. et al. (2006) Platelet dose consistency and its effect on number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion, 46, 24-33.
18. Norol, F., Kuentz, M., Cordonnier, C., Beaujean, F., Haioun, C., Vernant, J.P. & Duedari, N. (1994) Influence of clinical status on the efficiency of stored platelet transfusion. British Journal of Haematology, 86, 125-129.
19. Peter-Salonen, K., Bucher, U. & Nydegger, U.E. (1987) Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates. Blut, 54, 207-212.
20. Simonsen, A.C., Johansson, P.I., Conlan, M.G. et al. (2006) Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia - a pilot study. Transfusion, 46, 424-433.
21. Slichter, S.J. (2004) Platelet transfusion - future directions. Vox Sanguinis, 87 (Suppl. 2), S47-S51.
22. Slichter, S.J., Davis, K., Enright, H. et al. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood, 105, 4106-4114.
23. Strauss, R.G. (2001) Economy of platelet transfusions from a hospital perspective - pricing predicates practice. Transfusion, 41, 1617-1624.
24. van Rhenen, D., Gulliksson, H., Cazenave, J.-P. et al. (2003) Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood, 101, 2426-2433.